tiprankstipranks
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market

Day One Biopharmaceuticals (DAWN) Stock Investors

163 Followers
Based on 729,985 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DAWN
On average, investors allocate 2.37% of their portfolios to DAWN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 729,985 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DAWN

7.4%
Last 7
Days
15.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DAWN, out of 729,985 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DAWN Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.42%
$16.89
Based on the activity of 13,712 investors who made their portfolios public
The table shows changes in DAWN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DAWN Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.63%
-0.03%
-4.95%
39.64B
Technology
Riot Platforms
5.21%
+3.75%
+2.83%
3.00B
Financial
Marathon Digital Holdings
5.64%
+0.31%
-2.68%
5.49B
Financial
ChargePoint Holdings
3.88%
-1.04%
-7.27%
567.30M
Consumer Cyclical
Coherus Biosciences
2.67%
-1.40%
-8.90%
247.43M
Healthcare
Merck & Company
4.12%
+0.09%
-1.16%
321.34B
Healthcare
Marvell
4.79%
+0.63%
+4.97%
55.30B
Technology
Airbnb
4.81%
-1.06%
-5.80%
103.96B
Consumer Cyclical
Devon Energy
5.59%
-1.15%
-5.26%
33.38B
Energy
Delta Air Lines
5.62%
-0.96%
-2.66%
31.77B
Industrials
Based on the activity of 729,985 active portfolios
Open your Smart Portfolio

DAWN Investor Analysis

DAWN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.4%
of DAWN holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
DAWN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
30.8%
of DAWN holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
DAWN investors over 55

Over 55

7.2%
Last 30 days
Holdings Change
53.8%
of DAWN holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of DAWN stock investors
See who invests in DAWN according to age group and performance.

FAQ

How many retail Investors hold DAWN?
<0.1% of TipRanks' retail investors hold DAWN in their portfolios.
    What is DAWN Investor Sentiment?
    DAWN’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of DAWN in the last 7 days?
      ▲ 7.4% of TipRanks' retail investors changed their holding of DAWN in the last 7 days.
        What percentage of retail investors changed their holding of DAWN in the last 30 days?
        ▲ 15.1% of TipRanks' retail investors changed their holding of DAWN in the last 30 days.
          What is the average age of retail investors who hold DAWN?
          The average age of DAWN Holders is over 55.
            What other stocks have DAWN investors also bought?
            DAWN Investors also bought TTD, RIOT, MARA, CHPT, CHRS, MRK, MRVL, ABNB, DVN, DAL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              GERNGeron
              HCAHCA Healthcare
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis